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More Genes for Psoriasis
If the genetics of complex diseases is going to produce
therapeutic advance, psoriasis is perhaps the best place to
start. Psoriasis has one of the highest heritabilities of any
common inflammatory disease and, just to make the deci-
sion easier, we have astonishingly little insight into key en-
vironmental determinants. Unlike, say, atopy, where marked
secular changes have reportedly occurred, psoriasis epi-
demiology seems remarkably boring and uniform.
Over the last several years, there has been an epidemic
of allelic association studies published for many diseases,
many in the Journal, and yet, armchair enthusiasts will no-
tice that they have often been beset my methodological
problems. All too often they have been less than statistically
robust, and the magnitude of the effect size, smaller than the
author’s, and more importantly, the readers would wish for.
Donn and colleagues in this issue report a positive as-
sociation between macrophage migration inhibitory factor
promoter polymorphisms and psoriasis. The magnitude of
the odds ratio is, again, small (1.5–1.7), but in the authors’
favor they have functional evidence that the promoter po-
lymorphism studies are functionally significant, and that the
amounts of their gene product are altered in psoriasis.
Which way is the field going and how does this paper
help? First, once we exclude human leucocyte antogen
(HLA) effects, we have lost perhaps half of the heritability of
psoriasis. Researchers are left trying to apportion this re-
maining variability between an ever-increasing range of loci.
Second, and here is a paradox, we feel happier with asso-
ciations we can predicate on a mechanistic model (in the
case of this study, what was known about this cytokine), but
what we want the genetics to do is to point us in the di-
rection of pathways we did not know about. Otherwise, re-
verse genetics has become synonymous with biochemistry,
losing some of its ability to offer magical insights along the
way. Given that disease-state prediction is not critical, then
this all means that either we have to get used to betting on
weak evidence or cast around for some new insights.
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